7.00-7.30 Registration

7.25-7.30 Welcome & opening remarks : Banke Agarwal

Session I

7.30-9.15 Multidisciplinary management of esophageal cancers

Moderators : Gary Ratkin and Keith Naunheim

7.30-7.45 State of the art in esophageal adenocarcinoma : Gary Falk
  • Results of screening, surveillance and prevention of esophageal adenocarcinoma in last 25 years

Role of a therapeutic endoscopist in the management of esophageal cancer : staging and palliation : Douglas Faigel
  • EUS for staging of Esophageal cancer
    • Pre-treatment staging- what information can be obtained and always be provided
    • EUS restaging after chemo-XRT: its potential benefits in treatment planning
  • Endoscopic stent placement:
    • What is the right time in course of esophageal cancer to place stents
    • Stents vs PEG for nutritional supplementation
8.00-8.15 Surgery for patients with esophageal cancer : Cameron D Wright
  • Types of surgical operations available for esophageal cancer
  •  What are the advantages and disadvantages of each operation
  • Patient selection for surgery
8.15-8.30 Advances in the management of esophageal adenocarcinoma : David Ilson
  • What are the major oncologic achievements in their management
  • How these have impacted patient survival and quality of life
8.30-9.15 Q&A and case studies
9.15-9.30 Coffee Break & Visit Exhibits

Session II

9.30-11.00 Innovations in endoscopic management

Moderators : Steven Fern and Steven Edmundowicz

9.30-9.45 Endoscopic ablation of mucinous cysts in pancreas : John DeWitt

EUS guided biliary drainage in patients with unresectable pancreatic tumors : Janak Shah
10.00-10.15 Trans-anal endoscopic microsurgery : Eric Lederman
10.15-10.30 Cryoablation for early esophageal cancers and Barrett’s esophagus : John Dumot

Session III

11.00 -12.00 Steps to minimize medical lawsuits

Moderators : Shaun Falvey and Erik Thyssen

Panelists : Andrew Schlafly and Jeff Segal

12.00-1.00 Lunch

Session IV

1.00-2.45 Management of Pancreatic cancer

Moderators : Todd Howard and Giuseppe Aliperti


Surgery for pancreatic cancer: Patient selection and pre-operative staging : David Linehan
  • Role of pre-operative tissue diagnosis
    • What is the false positive rate for malignancy when patients are operated for pancreatic cancer without tissue diagnosis
    • When during surgery does the surgeon realize that there is no cancer in patients without pancreatic cancer
  • Pre-operative staging work-up
    • Pancreatic protocol CT
    • PET scan
    • Staging laparoscopy
  • Patient selection: age, tumor size, vascular infiltration
  • Vascular reconstruction to achieve R0 resection- Is there any survival benefit
1.15-1.30 Interventional EUS in management of patients with pancreatic cancer : Michael Levy
  • Pain control with celiac plexus neurolysis
  • EUS-guided injection of chemotherapeutic agents/biologic agents for treatment of pancreatic cancer
  • Placement of fiducials for guided radiotherapy

Role of chemoradiation in management patients with pancreatic and biliary cancer : Margaret Tempero
  • Pre-operative chemoradiation- its role in respectable and borderline resectable tumors
  • Post-operative chemoradiation for pancreatic cancer. Who needs it and what does it accomplish
  • Chemoradiation for locally advanced cancers- what does it accomplish
  • Metastatic pancreatic cancer: role of palliative chemoradiation
  • Recurrent pancreatic cancer: Does chemotherapy +/- radiation improve survival/quality of life

Determinants of survival benefit after R0 resection of pancreatic cancer : Banke Agarwal
  • Influence of tumor size, peripancreatic lymp nodes, patient age and perineural tumor infiltration on survival
  • Identification of subset of patients who most benefit from R0 resection of pancreatic cancer.
2.00-2.45Q&A and case studies
2.45-3.00Coffee break

Session V

3.00-4.00 Medical ethics : case studies

Moderators : Friedrich G. Schuening and Ira Kodner

Session VI

4.00-5.30 The future of colon cancer screening

Moderators : David Cort and Timothy Brady

4.00-4.15Anticipated issues in reimbursement for screening colonoscopy : Joel Brill
  • RUC review of colonoscopy codes
  • Carve out for sedation
  • Pathology and Anesthesia

PQRI and GIQuIC and AGA Health outcomes registry: What do we need to know and how can the data so generated be leveraged for better reimbursements : Brian Jacobson
4.30-4.45Update on competing technologies for colon cancer screening : Douglas Rex
  • Virtual colonoscopy, serum markers, capsule colonoscopy, other alternate colonoscopy techniques that require lower skill levels
  • Are they going to compete with colonoscopy for colon cancer screening any time in near future
  • What advantage does colonoscopy have on these technologies and what can we do to maintain it

Cost and time efficient use of newer techniques to improve the yield of screening and surveillance colonoscopy in practice settings : Klaus Mergener
5.00-5.30Q&A and case studies
5.30 pmConference adjourned